Nymox Pharma (NYMX) Reports Q3 Loss of $0.02/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts NYMX Hot Sheet
Join SI Premium – FREE
Nymox Pharma (NASDAQ: NYMX) reported Q3 EPS of ($0.02), versus ($0.03) reported last year. Revenue for the quarter came in at $81.1 thousand, versus $88.9 thousand reported last year.
For earnings history and earnings-related data on Nymox Pharma (NYMX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
- Figure Technology Solutions reports Q3 2026 loan volume of $5.12B
- Morgan Stanley reinstates this AI chipmaker as its top pick in semiconductors
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
